Catalyst Wire Dossier Catalyst Wire Dossier

RIFADIN IV

rifampin · Sanofi-Aventis U.S. LLC
Drug timelines are a Plus or Pro feature.

20 regulatory and trial events tracked for RIFADIN IV, covering 2010-11-10 to 2025-12-05. Get the full timeline:

Most recent: FDA Approved: RIFADIN IV — Supplemental Application (Sanofi-Aventis U.S. LLC)

See pricing